Taipei Exchange - Delayed Quote TWD

GeneReach Biotechnology Corp. (4171.TWO)

Compare
28.40
-0.30
(-1.05%)
At close: 1:30:31 PM GMT+8

Key Executives

Amounts are as of -- and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in TWD.
NameTitlePayExercisedYear Born
David Tsai Ph.D. Chief Operation Officer -- -- --
Alison Lee Chief Technology Officer -- -- --
Yu-Wen Huang Vice President of Compliance Operation -- -- --
Simon Chung Chief Commercial Officer -- -- --

GeneReach Biotechnology Corp.

Central Science Park
No.19, Keyuan 2nd Road Xitun District
Taichung, 407
Taiwan
886 4 2463 9869 https://www.genereach.com
Sector: 
Healthcare
Industry: 
Biotechnology

Description

GeneReach Biotechnology Corp. develops, manufactures, and markets products for applied nucleic acid detection technology in Taiwan. The company offers automatic nucleic acid extraction systems, prep homogenization system, and mini centrifuge equipment; and reagents and consumables, comprising human IVD assays, iiPCR specific reagents, taco nucleic acid extraction reagents, IQ real quantitative systems, IQ2000 detection and prevention systems, and research reagents and consumables. The company also provides polymerase chain reaction training programs, molecular diagnostic technical solutions, laboratory installation services, OEM/ODM contract manufacturing services, and research collaboration services. It serves aquaculture, agriculture, food, and human health industries, as well as companion animals and livestock. GeneReach Biotechnology Corp. was founded in 2004 and is headquartered in Taichung, Taiwan.

Corporate Governance

GeneReach Biotechnology Corp.’s ISS Governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder Rights: N/A; Compensation: N/A.
Corporate governance scores courtesy of Institutional Shareholder Services (ISS) Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while a 10 indicates higher governance risk.

Upcoming Events

Recent Events

July 28, 2023 at 12:00 AM UTC

Ex-Dividend Date

Related Tickers

6492.TWO Senhwa Biosciences, Inc.
42.35
+0.47%
 
4133.TW Abnova (Taiwan) Corporation
29.80
-1.16%
 
3205.TWO Sagittarius Life Science Corp
33.95
-1.59%
 
3176.TWO Medigen Biotechnology Corp.
32.60
-1.21%
 
4130.TWO Genovate Biotechnology Co., Ltd.
25.30
+1.81%
 
4167.TWO Savior Lifetec Corporation
19.75
-0.25%
 
1760.TW Panion & Bf Biotech Inc.
82.70
+1.10%
 
4157.TWO TaiGen Biopharmaceuticals Holdings Limited
10.70
0.00%
 
1762.TW Chunghwa Chemical Synthesis & Biotech Co., Ltd.
33.20
+0.30%
 
4162.TWO PharmaEngine, Inc.
95.10
+2.15%